CARLSBAD – After demonstrating early clinical success in its OpRegen ophthalmology program, Lineage Cell Therapeutics (NYSE: LCTX) has set its …
Lineage Looking to Restore Sight, Hearing, Movement – San Diego Business Journal
In
CARLSBAD – After demonstrating early clinical success in its OpRegen ophthalmology program, Lineage Cell Therapeutics (NYSE: LCTX) has set its …
In